BVF INC/IL Diversified Active

CIK: 0001056807 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 14, 2016

Total Value ($000): $530,675 (99.5% shares, 0.5% debt)

Holdings (29)

— BLUEPRINT MEDICINES CORP 15.5%

Value ($000) $82,123 Shares 2,765,080 Est. Cost $24.64 Unrealized —

— CHEMOCENTRYX INC 9.2%

Value ($000) $48,707 Shares 8,064,019 Est. Cost $8.96 Unrealized —

CYTK CYTOKINETICS INC 8.6%

Value ($000) $45,873 Shares 4,997,071 Est. Cost $7.03 Unrealized +48.5%

— ARRAY BIOPHARMA INC 8.2%

Value ($000) $43,613 Shares 6,461,186 Est. Cost $4.28 Unrealized —

— CASCADIAN THERAPEUTICS INC 5.8%

Value ($000) $30,831 Shares 18,799,368 Est. Cost $0.94 Unrealized —

— FORWARD PHARMA A/S 5.5%

Value ($000) $29,145 Shares 1,387,853 Est. Cost $20.85 Unrealized —

— COLUCID PHARMACEUTICALS INC 5.5%

Value ($000) $29,120 Shares 763,300 Est. Cost $38.15 Unrealized —

— CONCERT PHARMACEUTICALS INC 5.2%

Value ($000) $27,532 Shares 2,723,210 Est. Cost $13.78 Unrealized —

XENE XENON PHARMACEUTICALS INC 4.7%

Value ($000) $25,182 Shares 3,108,905 Est. Cost $9.33 Unrealized -17.2%

— ONCOMED PHARMACEUTICALS INC 3.9%

Value ($000) $20,711 Shares 1,812,005 Est. Cost $16.92 Unrealized —

— GLYCOMIMETICS INC 3.3%

Value ($000) $17,348 Shares 2,426,282 Est. Cost $7.27 Unrealized —

— CTI BIOPHARMA CORP 3.2%

Value ($000) $16,767 Shares 44,796,940 Est. Cost $1.27 Unrealized —

— TOBIRA THERAPEUTICS INC 3.0%

Value ($000) $15,873 Shares 399,433 Est. Cost $16.80 Unrealized —

— NIVALIS THERAPEUTICS INC 2.6%

Value ($000) $13,900 Shares 1,709,673 Est. Cost $6.47 Unrealized —

— ARQULE INC 2.5%

Value ($000) $13,246 Shares 7,400,128 Est. Cost $1.87 Unrealized —

CTMX CYTOMX THERAPEUTICS INC 1.7%

Value ($000) $9,280 Shares 591,813 Est. Cost $15.82 Unrealized -23.5%

— IMMUNE DESIGN CORP 1.7%

Value ($000) $9,096 Shares 1,200,000 Est. Cost $7.58 Unrealized —

— GTX INC DEL 1.7%

Value ($000) $9,014 Shares 11,512,000 Est. Cost $0.72 Unrealized —

INFIQ INFINITY PHARMACEUTICALS INC 1.5%

Value ($000) $8,033 Shares 5,149,644 Est. Cost $4.68 Unrealized -67.1%

PTGX PROTAGONIST THERAPEUTICS INC 1.5%

Value ($000) $7,924 Shares 375,000 Est. Cost $13.67 Unrealized 0.0%

ESPR ESPERION THERAPEUTICS INC NE 1.3%

Value ($000) $6,840 Shares 493,872 Est. Cost $16.09 Unrealized -29.5%

— ADURO BIOTECH INC 1.2%

Value ($000) $6,229 Shares 501,155 Est. Cost $11.31 Unrealized —

— SUNESIS PHARMACEUTICALS INC 0.6%

Value ($000) $3,192 Shares 730,361 Est. Cost $4.37 Unrealized —

— OREXIGEN THERAPEUTICS INC 0.5%

Value ($000) $2,650 Shares 10,000,000 Est. Cost $0.27 Unrealized —

— OREXIGEN THERAPEUTICS INC 0.5%

Value ($000) $2,440 Shares 734,976 Est. Cost $3.32 Unrealized —

— PAIN THERAPEUTICS INC 0.4%

Value ($000) $2,278 Shares 2,278,552 Est. Cost $1.80 Unrealized —

— PIERIS PHARMACEUTICALS INC 0.4%

Value ($000) $1,858 Shares 1,016,593 Est. Cost $1.78 Unrealized —

— CATALYST BIOSCIENCES INC 0.2%

Value ($000) $1,048 Shares 865,773 Est. Cost $4.66 Unrealized —

GBIM GLOBEIMMUNE INC 0.2%

Value ($000) $822 Shares 657,653 Est. Cost $6.22 Unrealized -85.6%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	BLUEPRINT MEDICINES CORP	2,765,080	$82,123	15.5%	$24.64	—	COM	09627Y109
—	CHEMOCENTRYX INC	8,064,019	$48,707	9.2%	$8.96	—	COM	16383L106
CYTK	CYTOKINETICS INC	4,997,071	$45,873	8.6%	$7.03	+48.5%	COM NEW	23282W605
—	ARRAY BIOPHARMA INC	6,461,186	$43,613	8.2%	$4.28	—	COM	04269X105
—	CASCADIAN THERAPEUTICS INC	18,799,368	$30,831	5.8%	$0.94	—	COM	14740B101
—	FORWARD PHARMA A/S	1,387,853	$29,145	5.5%	$20.85	—	SPONSORED ADR	34986J105
—	COLUCID PHARMACEUTICALS INC	763,300	$29,120	5.5%	$38.15	—	COM	19716T101
—	CONCERT PHARMACEUTICALS INC	2,723,210	$27,532	5.2%	$13.78	—	COM	206022105
XENE	XENON PHARMACEUTICALS INC	3,108,905	$25,182	4.7%	$9.33	-17.2%	COM	98420N105
—	ONCOMED PHARMACEUTICALS INC	1,812,005	$20,711	3.9%	$16.92	—	COM	68234X102
—	GLYCOMIMETICS INC	2,426,282	$17,348	3.3%	$7.27	—	COM	38000Q102
—	CTI BIOPHARMA CORP	44,796,940	$16,767	3.2%	$1.27	—	COM	12648L106
—	TOBIRA THERAPEUTICS INC	399,433	$15,873	3.0%	$16.80	—	COM	88883P101
—	NIVALIS THERAPEUTICS INC	1,709,673	$13,900	2.6%	$6.47	—	COM	65481J109
—	ARQULE INC	7,400,128	$13,246	2.5%	$1.87	—	COM	04269E107
CTMX	CYTOMX THERAPEUTICS INC	591,813	$9,280	1.7%	$15.82	-23.5%	COM	23284F105
—	IMMUNE DESIGN CORP	1,200,000	$9,096	1.7%	$7.58	—	COM	45252L103
—	GTX INC DEL	11,512,000	$9,014	1.7%	$0.72	—	COM	40052B108
INFIQ	INFINITY PHARMACEUTICALS INC	5,149,644	$8,033	1.5%	$4.68	-67.1%	COM	45665G303
PTGX	PROTAGONIST THERAPEUTICS INC	375,000	$7,924	1.5%	$13.67	0.0%	COM	74366E102
ESPR	ESPERION THERAPEUTICS INC NE	493,872	$6,840	1.3%	$16.09	-29.5%	COM	29664W105
—	ADURO BIOTECH INC	501,155	$6,229	1.2%	$11.31	—	COM	00739L101
—	SUNESIS PHARMACEUTICALS INC	730,361	$3,192	0.6%	$4.37	—	COM PAR	867328700
—	OREXIGEN THERAPEUTICS INC	10,000,000	$2,650	0.5%	$0.27	—	NOTE 2.750%12/0	686164AB0
—	OREXIGEN THERAPEUTICS INC	734,976	$2,440	0.5%	$3.32	—	COM NEW	686164302
—	PAIN THERAPEUTICS INC	2,278,552	$2,278	0.4%	$1.80	—	COM	69562K100
—	PIERIS PHARMACEUTICALS INC	1,016,593	$1,858	0.4%	$1.78	—	COM	720795103
—	CATALYST BIOSCIENCES INC	865,773	$1,048	0.2%	$4.66	—	COM	14888D109
GBIM	GLOBEIMMUNE INC	657,653	$822	0.2%	$6.22	-85.6%	COM	37957B100